[SIEN] Sientra, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Industrial Specialties

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 8.6 Change: 0.27 (3.24%)
Ext. hours: Change: 0 (0%)

chart SIEN

Refresh chart

Strongest Trends Summary For SIEN

SIEN is in the medium-term down -25% in 1 month and down -50% in 5 months and down -73% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons and patients in the United States. The company offers a portfolio of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders. It also provides body contouring and other implants, including gluteal, pectoral, calf, facial, and nasal implants, as well as nasal stents; silicone elastomer oval carving blocks to treat deformity caused by trauma, congenital and other deformities, or cancer therapy; scar management specialty products under the Medgel brand to treat various types of scars; breast sizers to identify the style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barb

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 16.53% Sales Growth - Q/Q2.62% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-5.9% ROE-8.65% ROI-7.08%
Current Ratio5.34 Quick Ratio4.47 Long Term Debt/Equity0.2 Debt Ratio0.24
Gross Margin73.65% Operating Margin-16.57% Net Profit Margin-22.81% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-30 K Cash From Investing Activities-140 K Cash From Operating Activities-2.97 M Gross Profit9.2 M
Net Profit-3.38 M Operating Profit-2.63 M Total Assets136.1 M Total Current Assets120.69 M
Total Current Liabilities22.61 M Total Debt25.55 M Total Liabilities43.27 M Total Revenue12.43 M
Technical Data
High 52 week25.57 Low 52 week7.3 Last close8.35 Last change-3.24%
RSI56.69 Average true range0.54 Beta1.04 Volume75.14 K
Simple moving average 20 days4.87% Simple moving average 50 days-9.28% Simple moving average 200 days-48.72%
Performance Data
Performance Week1.83% Performance Month-3.36% Performance Quart-31.16% Performance Half-61.14%
Performance Year-37.17% Performance Year-to-date-34.3% Volatility daily3.29% Volatility weekly7.36%
Volatility monthly15.08% Volatility yearly52.25% Relative Volume72.8% Average Volume857.8 K
New High New Low

News

2019-06-13 09:15:01 | Stocks Take Another Small Step Back

2019-06-07 16:01:00 | Sientra, Inc. Closes $115 Million Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares

2019-06-05 15:14:58 | Wells Fargo Upgrades Sientra After FDA, Financing Concerns Ease

2019-06-04 18:30:00 | Sientra Announces Pricing of Upsized Public Offering of Common Stock

2019-06-04 07:00:00 | Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635c4

2019-06-03 16:02:00 | Sientra Commences Public Offering of Common Stock

2019-05-09 11:24:02 | Sientra SIEN Q1 2019 Earnings Call Transcript

2019-05-09 01:35:27 | Edited Transcript of SIEN earnings conference call or presentation 8-May-19 8:30pm GMT

2019-05-08 16:29:21 | Sientra: 1Q Earnings Snapshot

2019-05-08 16:01:00 | Sientra Reports First Quarter 2019 Financial Results

2019-05-01 10:32:02 | Sientra SIEN May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-04-22 16:32:00 | Here's Why Sientra's Shares Got a Lift Today

2019-04-18 16:15:00 | Sientra to Release First Quarter Financial Results on May 8, 2019

2019-04-17 13:51:31 | Those Who Purchased Sientra NASDAQ:SIEN Shares A Year Ago Have A 32% Loss To Show For It

2019-03-20 16:26:55 | Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter

2019-03-19 19:34:03 | J&J and Sientra get FDA warning letters over breast implants

2019-03-15 11:45:05 | Read This Before Selling Sientra, Inc. NASDAQ:SIEN Shares

2019-03-13 17:17:09 | Vera Bradley and Guardant Health surge while Express falls

2019-03-13 13:31:23 | Edited Transcript of SIEN earnings conference call or presentation 12-Mar-19 8:30pm GMT

2019-03-13 13:18:00 | Here's Why Sientra Stock Is Plummeting Today

2019-03-13 11:25:00 | Sientra Plunges After Posting Wider-Than-Expected Loss

2019-03-13 02:50:22 | Sientra Inc SIEN Q4 2018 Earnings Conference Call Transcript

2019-03-12 17:15:09 | Sientra SIEN Reports Q4 Loss, Tops Revenue Estimates

2019-03-12 16:28:30 | Sientra: 4Q Earnings Snapshot

2019-03-12 16:01:00 | Sientra Reports Fourth Quarter and Full Year 2018 Financial Results

2019-03-12 14:30:00 | Sientra, Inc. to Host Earnings Call

2019-03-04 16:44:35 | Sientra® to Release Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019

2019-02-26 08:15:00 | Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental — Emerging Consolidated Expectations, Analyst Ratings

2019-02-19 16:01:00 | Sientra to Present at the 8th Annual SVB Leerink Global Healthcare Conference

2019-02-13 10:33:17 | What You Must Know About Sientra, Inc.’s NASDAQ:SIEN Financial Strength

2019-02-05 16:44:15 | Sientra Announces miraDry Leadership Transition

2019-02-01 16:01:00 | Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635c4

2019-01-07 08:00:00 | Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors

2018-12-23 02:48:17 | Is Sientra Inc SIEN A Good Stock To Buy?

2018-12-12 11:22:41 | How Much Did Sientra, Inc.’s NASDAQ:SIEN CEO Pocket Last Year?

2018-12-10 08:01:00 | Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635c4

2018-11-27 08:45:00 | New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-11-12 08:41:01 | Implied Volatility Surging for Sientra SIEN Stock Options

2018-11-07 01:30:11 | Edited Transcript of SIEN earnings conference call or presentation 6-Nov-18 9:30pm GMT

2018-11-06 18:15:11 | Sientra SIEN Reports Q3 Loss, Tops Revenue Estimates

2018-11-06 17:11:43 | Sientra: 3Q Earnings Snapshot

2018-11-06 16:01:00 | Sientra Reports Third Quarter 2018 Financial Results

2018-10-31 16:01:00 | Sientra to Participate in Upcoming Investor Conferences

2018-10-23 16:05:00 | Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018

2018-10-23 05:00:00 | Sientra Announces FULL CIRCLE Grant Recipients

2018-10-16 07:55:00 | Investor Expectations to Drive Momentum within Cincinnati Bell, Hooker Furniture, AgroFresh Solutions, Forward Industries, Abeona Therapeutics, and Sientra — Discovering Underlying Factors of Influence

2018-10-12 08:56:12 | Are Options Traders Betting on a Big Move in Sientra SIEN Stock?

2018-09-19 15:36:33 | SEC sues U.S. breast-implant company's ex-CEO after stock dive

2018-09-19 14:35:44 | SEC sues ex-CEO of California breast implant company after stock nosedived

2018-08-16 07:35:00 | Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences — Research Highlights Growth, Revenue, and Consolidated Results